聚山梨酯20檢測

聚山梨酯20檢測項(xiàng)目報(bào)價(jià)？??解決方案？??檢測周期？??樣品要求？

點(diǎn) 擊 解 答??

DIN EN ISO 20776-1-2007臨床實(shí)驗(yàn)室試驗(yàn)和在玻璃試管內(nèi)診斷試驗(yàn)系統(tǒng).傳染介質(zhì)易傳染性試驗(yàn)和抗菌易傳染性試驗(yàn)裝置性能評估

This part of ISO 20776 describes one reference method, broth microdilution, for determination of MICs. The MIC reflects the activity of the drug under the described test conditions, and can be interpreted for clinical management purposes by taking into account other factors, such as drug pharmacology or bacterial resistance mechanisms. This allows categorization of bacteria as "susceptible" (S), "intermediate" (I), or "resistant" (R). In addition, MIC distributions can be used to define wild type or non-wild type bacterial populations. Although clinical interpretation of the MIC value is beyond the scope of this part of ISO 20776, A modifications of the basic method are required for certain antimicrobial agent - bacteria combinations to facilitate clinical interpretation. These modifications are included in a separate table. It is advisable to compare other susceptibility testing methods (e.g. routine methods or diagnostic test devices) with this reference method for validation, in order to ensure comparable and reliable results.